SCHEMBL7644584

SCHEMBL7644584

CCCCNc1ccc2nc(N[C@@H]3CCc4ccccc43)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PFKFB3 Q16875 7/20 0.39
FADS1 O60427 1/20 0.39
PDPK1 O15530 1/20 0.38
HPGDS O60760 1/20 0.38
CDK1 P06493 1/20 0.37
TLR8 Q9NR97 1/20 0.37
EGFR P00533 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
BCHE P06276 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7602632 0.90 PFKFB3 (0.40) PFKFB3FADS1PDPK1HPGDSCDK1
SCHEMBL7606688 0.89 PFKFB3 (0.42) PFKFB3FADS1PDPK1HPGDSCDK1
SCHEMBL4109902 0.79 MAPT (0.44) PFKFB3FADS1PDPK1HPGDSKDM4E
SCHEMBL3408320 0.79 HPGDS (0.37) PFKFB3HPGDSKDM4ELMNAALOX15
SCHEMBL3410594 0.79 NPY1R (0.40) HPGDSKDM4ELMNAALOX15TSHR
SCHEMBL3429547 0.78 PFKFB3 (0.39) PFKFB3FADS1PDPK1HPGDSCDK1
SCHEMBL3415257 0.78 HPGDS (0.46) PFKFB3FADS1PDPK1HPGDSEGFR
SCHEMBL3411790 0.78 NPC1 (0.42) PFKFB3FADS1PDPK1HPGDSLMNA
SCHEMBL7602597 0.77 CA1 (0.49) PFKFB3FADS1HPGDSCDK1KDM4E
SCHEMBL3414984 0.77 AURKA (0.41) PFKFB3FADS1HPGDSCDK1DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227570-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2A PFKFB3 2701/4885FADS1 2068/4885PDPK1 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.